2025 SPS Minneapolis | Tarlatamab in Neuroendocrine Tumors:  Clinical Implications & Challenges of Antibody Drug Conjugates

2025 SPS Minneapolis | Tarlatamab in Neuroendocrine Tumors: Clinical Implications & Challenges of Antibody Drug Conjugates

0% Complete

Course Overview

NA

Course Content

Course Details

Duration
0.00 hour
Released
Sep 13, 2025
Last Review
Sep 13, 2025
Expires
Sep 13, 2026

Objectives

NA

Target Audience

Pharmacists

Faculty & Disclosure

Faculty

Marie Parish, PharmD, BCOP

Disclosure

<p>Marie Parish, PharmD, BCOP </p>

Accreditation

NA